M. Zaigham, O. Andersson. Maternal and Perinatal Outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. (2020);10.1111/aogs.13867.
 M. Knight, K. Bunch, N. Vousden, E. Morris, N. Simpson, C. Gale et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ (2020); 369 :m2107
 Royal College of Obstetricians and Gynaecologists and The Royal College of Midwives. Coronavirus (COVID-19) Infection in Pregnancy: Information for healthcare professionals. In: Royal College of Obstetricians and Gynaecologists, ed. London, (2020).
 Swedish National Board of Health and Welfare’s report on: Risk groups with the highest risk of severe COVID-19 infection. (2020). https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/dokument-webb/ovrigt/identifiering-av-riskgrupper-covid19.pdf (Accessed 6th June 2020)
 Y. Liu, H. Chen, K. Tang, Y. Guo. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. (2020); S0163-4453:30109-2.
 M.M. Ramos Amorim, M.L. Soligo Takemoto, E.B. Fonseca. Maternal Deaths with Covid19: a different outcome from mid to low resource countries? American Journal of Obstetrics and Gynecology (2020). [Epub ahead of print]
 R.A.M Pierce-Williams, J. Burd, L. Felder et al. Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study [published online ahead of print, 2020 May 8]. Am J Obstet Gynecol MFM. (2020);100134.
 The OpenSAFELY Collaborative. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients (2020) Preprint available at: https://doi.org/10.1101/2020.05.06.20092999
 L. Lansbury L, C. Rodrigo, J. Leonardi-Bee, J. Nguyen-Van-Tam, W.S. Lim. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev (2019); 2: CD010406
 L.C. Poon, H. Yang, S. Dumont, J.C.S. Lee, J.A. Copel, L. Danneels et al. ISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals – an update. Ultrasound Obstet Gynecol (2020). DOI: 10.1002/uog.22061.
 SFOG recommendations on the management of pregnant women and infants to women with COVID-19. Available in Swedish at: https://www.sfog.se/media/336929/sfog-raad-om-handlaeggning-av-gravida-och-barn-till-kvinnor-med-verifieradelsannolik-covid-19_ver-2_200405.pdf Accessed 6th June, 2020.
 Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. Available at: https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_final.pdf Acccessed 17th June, 2020.
 J. Villar, C. Ferrando, D. Martínez, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med (2020);8(3):267-76.
 L.A. Henderson, S.W. Canna, G.S Schulert, S. Volpi, P.Y. Lee, K. Kernan et al. On the alert for cytokine storm: Immunopathology in COVID‐19. Arthritis Rheumatol. (2020) Accepted Author Manuscript. [Epub ahead of print]
 Q. Ruan, K. Yang, W. Wang, L. Jiang, J. Song. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intens Care Med (2020) [Epub ahead of print].
 L. Ronnje, J.K. Länsberg, O. Vikhareva et al. Complicated COVID-19 in pregnancy: a case report with severe liver and coagulation dysfunction promptly improved by delivery, (2020), PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-31225/v1]
 M. Jin, Q. Tong. Rhabdomyolysis as Potential Late Complication Associated with COVID-19 [published online ahead of print, 2020 Mar 20]. Emerg Infect Dis. (2020);26(7):10.